Programme Category
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Identifier Code
Call
Summary
Companies are therefore increasingly raising funding to support their preclinical CVD programs aimed to develop key molecules that can disrupt signalling pathways that regulate key cardiovascular processes including rhythm, hypertrophy, contractility, and autophagy and others, potentially leading to new therapies for heart failure or other CVD conditions. The overall aim of this Challenge is to pave the way for novel therapies
for major CVD conditions including hemorrhagic and ischemic stroke, aneurysm, cardiomyopathy and certain types of arrhythmias and other conditions, for which no effective treatments are currently available.
The gender dimension in research content should be considered, where relevant.
Detailed Call Description
The following specific objectives have been identified for this Challenge:
- to identify single or multiple gene variants of high biological significance or other key molecules associated with the CVDs that would allow for accurate stratification of patients and guide the physician in their clinical management and monitoring of these CVDs;
- to identify novel targets based on these variants for specific CVD indication(s) that would allow for the development of first in class therapies for the same indication;
to seek for novel technological solutions that could contribute to the development and acceleration of first in class therapies for major CVD conditions for which no effective treatments are currently available.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
The total indicative budget of the present call is € 167 000 000 which is expected to be allocated in approximately equal shares across the challenges. The EIC considers proposals with an EU contribution of up to € 4 000 000 as appropriate.
The funding rate of this grant will be 100% of the eligible costs.
In addition to funding, projects will receive tailor-made access to a wide range of Business Acceleration Services.
Thematic Categories
- Health
- Information Technology
- Research, Technological Development and Innovation
Eligibility for Participation
- Associations
- Central Government
- Chambers
- Consumer Organisations
- International Organisations
- Large Enterprises
- Legal Entities
- Local Authorities
- Local Authority clusters
- NGOs
- Non Profit Organisations
- Private Bodies
- Researchers/Research Centers/Institutions
- Semi-governmental organisations
- Services Providers
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
Call Opening Date
Call Closing Date
National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
Phone Number: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Persons:
Charalambos Papatryfonos, Scientific Officer
Contact Phone: +357 22 205 016
Contact Email: cpapatryfonos@research.org.cy
Marinos Photiades, Scientific Officer
Contact Phone: +357 22 205 048
Contact Email: mphotiades@research.org.cy
EU Contact Point
Research Enquiry Service: https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en